British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half ...

Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...

HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.

Sign up here to find us in your inbox every Wednesday, along with monthly travel and beauty guides, and the latest stories ...

Boss Mark Read (pictured) said that although revenues were hit by weaker client discretionary spending, growth of 2% was seen ...

MORE than a dozen FTSE companies dumped their figures on the City yesterday to comply with rules to report within three ...

Q4 2024 Earnings Conference Call February 27, 2025 4:00 AM ETCompany ParticipantsJo Russell - Head-Investor RelationsBrian McNamara ...

For 2025 Haleon expects organic revenue growth of 4% to 6%, organic operating profit growth ahead of organic revenue growth with both likely to be weighted towards the second half of the year. The ...

Consumer healthcare giant Haleon reiterated its full-year outlook on Thursday, after posting improved full-year sales and profits.

Ocado published its full year results this morning. Haleon's share price has also taken a hit after its revenues slipped 0.6% ...

The maker of Panadol, Sensodyne toothpaste and Centrum vitamins posted a higher pretax profit for 2024 despite lower revenue.

The FTSE 100 index closed up 24.75 points, 0.3%, at 8,756.21. The FTSE 250 ended down 181.17 points, 0.9%, at 20,414.73, while the AIM All-Share closed down 3.78 points, 0.5%, at 707.72.